A New Pipeline for the Normalization and Pooling of Metabolomics Data.

cancer epidemiology metabolites metabolomics normalization pooling technical variability

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
17 Sep 2021
Historique:
received: 15 07 2021
revised: 10 09 2021
accepted: 13 09 2021
entrez: 26 9 2021
pubmed: 27 9 2021
medline: 27 9 2021
Statut: epublish

Résumé

Pooling metabolomics data across studies is often desirable to increase the statistical power of the analysis. However, this can raise methodological challenges as several preanalytical and analytical factors could introduce differences in measured concentrations and variability between datasets. Specifically, different studies may use variable sample types (e.g., serum versus plasma) collected, treated, and stored according to different protocols, and assayed in different laboratories using different instruments. To address these issues, a new pipeline was developed to normalize and pool metabolomics data through a set of sequential steps: (i) exclusions of the least informative observations and metabolites and removal of outliers; imputation of missing data; (ii) identification of the main sources of variability through principal component partial R-square (PC-PR2) analysis; (iii) application of linear mixed models to remove unwanted variability, including samples' originating study and batch, and preserve biological variations while accounting for potential differences in the residual variances across studies. This pipeline was applied to targeted metabolomics data acquired using Biocrates AbsoluteIDQ kits in eight case-control studies nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Comprehensive examination of metabolomics measurements indicated that the pipeline improved the comparability of data across the studies. Our pipeline can be adapted to normalize other molecular data, including biomarkers as well as proteomics data, and could be used for pooling molecular datasets, for example in international consortia, to limit biases introduced by inter-study variability. This versatility of the pipeline makes our work of potential interest to molecular epidemiologists.

Identifiants

pubmed: 34564446
pii: metabo11090631
doi: 10.3390/metabo11090631
pmc: PMC8467830
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Bioinformatics. 2001 Jun;17(6):520-5
pubmed: 11395428
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
BMC Bioinformatics. 2019 Jun 14;20(1):334
pubmed: 31200644
Front Nutr. 2019 Apr 09;6:41
pubmed: 31024923
J Intern Med. 2020 Apr;287(4):405-421
pubmed: 31814205
Anal Chem. 2021 Mar 30;93(12):5028-5036
pubmed: 33724799
Stat Med. 2019 Apr 15;38(8):1303-1320
pubmed: 30569596
Am J Epidemiol. 2005 Sep 15;162(6):591-8
pubmed: 16093290
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Metabolites. 2013 Jul 05;3(3):552-74
pubmed: 24958139
Clin Chim Acta. 2018 Jul;482:78-83
pubmed: 29596816
Metabolomics. 2018 Sep 20;14(10):128
pubmed: 30830398
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
BMC Med. 2021 Apr 30;19(1):101
pubmed: 33926456
Int J Cancer. 2020 Feb 1;146(3):720-730
pubmed: 30951192
Bioinformatics. 2015 Mar 1;31(5):788-90
pubmed: 25348215
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Am J Epidemiol. 2019 Jun 1;188(6):991-1012
pubmed: 31155658
Nat Methods. 2016 Sep;13(9):770-6
pubmed: 27479327
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10101-6
pubmed: 10963673
Anal Chem. 2017 Jan 3;89(1):656-665
pubmed: 27959516
Bioinformatics. 2014 Aug 1;30(15):2155-61
pubmed: 24711654
BMC Med. 2017 Jul 5;15(1):122
pubmed: 28676103
BMC Med. 2019 Sep 24;17(1):178
pubmed: 31547832
Gynecol Oncol. 2021 Aug;162(2):475-481
pubmed: 34099314
Metabolites. 2019 Sep 23;9(10):
pubmed: 31548506
Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):531-540
pubmed: 29563134
Int J Cancer. 2016 Jan 15;138(2):348-60
pubmed: 26238458
Eur Heart J. 2020 Jul 21;41(28):2645-2656
pubmed: 32406924

Auteurs

Vivian Viallon (V)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Mathilde His (M)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Sabina Rinaldi (S)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Marie Breeur (M)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Audrey Gicquiau (A)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Bertrand Hemon (B)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Kim Overvad (K)

Department of Public Health, Aarhus University Bartholins Alle 2, DK-8000 Aarhus, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.

Agnetha Linn Rostgaard-Hansen (AL)

Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.

Joseph A Rothwell (JA)

UVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Université Paris-Saclay, Gustave Roussy, 94800 Villejuif, France.

Lucie Lecuyer (L)

UVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Université Paris-Saclay, Gustave Roussy, 94800 Villejuif, France.

Gianluca Severi (G)

UVSQ, Inserm, CESP U1018, "Exposome and Heredity" Team, Université Paris-Saclay, Gustave Roussy, 94800 Villejuif, France.
Department of Statistics, Computer Science, Applications "G. Parenti", University of Florence, 50134 Florence, Italy.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Theron Johnson (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam Rehbruecke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Claudia Agnoli (C)

Epidemiology and Prevention Unit Department of Research, Fondazione IRCCS-Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Salvatore Panico (S)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, 80131 Naples, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), 97100 Ragusa, Italy.

Fulvio Ricceri (F)

Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Unit of Epidemiology, Regional Health Service ASL TO3, 10095 Grugliasco, Italy.

W M Monique Verschuren (WMM)

National Institute for Public Health and the Environment, Centre for Nutrition, Prevention and Health Services, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands.

Peter Engelfriet (P)

National Institute for Public Health and the Environment, Centre for Nutrition, Prevention and Health Services, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands.

Charlotte Onland-Moret (C)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands.

Roel Vermeulen (R)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands.
Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, 3584 CM Utrecht, The Netherlands.

Therese Haugdahl Nøst (TH)

Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, P.O. Box 6050, 9037 Tromsø, Norway.

Ilona Urbarova (I)

Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, P.O. Box 6050, 9037 Tromsø, Norway.

Raul Zamora-Ros (R)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), 08908 L'Hospitalet de Llobregat, Spain.

Miguel Rodriguez-Barranco (M)

Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.

Pilar Amiano (P)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Ministry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, 20013 San Sebastián, Spain.
Biodonostia Health Research Institute, Group of Epidemiology of Chronic and Communicable Diseases, 20014 San Sebastián, Spain.

José Maria Huerta (JM)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30007 Murcia, Spain.

Eva Ardanaz (E)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
Navarra Public Health Institute, 31003 Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

Olle Melander (O)

Department of Clincal Sciences, Lund University, SE-21 428 Malmö, Sweden.
Department of Emergency and Internal Medicine, Skåne University Hospital, SE-20 502 Malmö, Sweden.

Filip Ottoson (F)

Department of Immunotechnology, Lund University, SE-22 100 Lund, Sweden.

Linda Vidman (L)

Department of Radiation Sciences, Oncology, Umeå University, SE-901 87 Umeå, Sweden.

Matilda Rentoft (M)

Department of Radiation Sciences, Oncology, Umeå University, SE-901 87 Umeå, Sweden.

Julie A Schmidt (JA)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Ruth C Travis (RC)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, World Health Organization, 69008 Lyon, France.

Mattias Johansson (M)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Laure Dossus (L)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Mazda Jenab (M)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Marc J Gunter (MJ)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Justo Lorenzo Bermejo (J)

Statistical Genetics Group, Institute of Medical Biometry, University of Heidelberg, 69120 Heidelberg, Germany.

Dominique Scherer (D)

Statistical Genetics Group, Institute of Medical Biometry, University of Heidelberg, 69120 Heidelberg, Germany.

Reza M Salek (RM)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Pekka Keski-Rahkonen (P)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Pietro Ferrari (P)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 69008 Lyon, France.

Classifications MeSH